Back to search
FDAFDA · Food and drugs·Recall number Z-0826-2022

CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179

Published April 6, 2022 · Recall initiated: January 11, 2022

Summary

FDA records medical device Class II recall Z-0826-2022, published April 6, 2022 and initiated January 11, 2022. Recalling firm: Diagnos Inc; Status: Terminated; Reported quantity: 1; Lot: Software Version 4.7.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Diagnos Inc
Distributor
US: CA
Lot
Software Version 4.7.2
Risk classification
Class II
Area (FDA)
device
Country
Canada

Related recalls

Questions about this recall

Was CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179 recalled?

Yes. FDA published recall Z-0826-2022 on April 6, 2022. Reported hazard: Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.

What should I do if I have this product?

Voluntary: Firm initiated · Letter